Work

Results of a Phase II Trial of Brentuximab Vedotin As First Line Salvage Therapy in Relapsed/Refractory HL Prior to AHCT

Year: 2014

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v124.21.501.501

Authors: Robert W Chen, Joycelynne Palmer, Peter Martin, Nicole Tsai, Young Kim, Michelle Mott, Firoozeh Sahebi, Tanya Siddiqi, Leslie L. Popplewell, John P. Leonard, Tsiporah B. Shore, Stephen J. Forman

Institutions: City Of Hope National Medical Center, City of Hope, Weill Cornell Medicine

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2491843532

FWCI: 2.844

Cites:

Cited by: 14

Related to: 10